Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study

References

• Greally M, Agarwal R, Ilson DH. Optimal management of gastroesophageal junction cancer. Cancer. 2019;125(12):1990–2001. doi:10.1002/cncr.32066
   PubMed Web of Science ®Google Scholar
• Chevallay M, Bollschweiler E, Chandramohan SM, et al. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci. 2018;1434(1):132–138. doi:10.1111/nyas.13954
   PubMed Web of Science ®Google Scholar
• Chiappa A, Andreoni B, Dionigi R, et al. A rationale multidisciplinary approach for treatment of esophageal and gastroesophageal junction cancer: accurate review of management and perspectives. Crit Rev Oncol Hematol. 2018;132:161–168. doi:10.1016/j.critrevonc.2018.10.002
   PubMed Web of Science ®Google Scholar
• Lagarde SM, Ten Kate FJ, Reitsma JB, et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. Am J Clin Oncol. 2006;24(26):4347–4355. doi:10.1200/JCO.2005.04.9445
   PubMed Web of Science ®Google Scholar
• Anker CJ, Dragovic J, Herman JM, et al. Executive summary of the American Radium Society appropriate use criteria for operable esophageal and gastroesophageal junction adenocarcinoma: systematic review and guidelines. Int J Radiat Oncol Biol Phys. 2021;109(1):186–200. doi:10.1016/j.ijrobp.2020.08.050
   PubMed Web of Science ®Google Scholar
• Mochizuki K, Kondo T, Oishi N, et al. Esophagogastric junction carcinomas - discriminating histological types through immunohistochemistry. Anticancer Res. 2017;37(12):6855–6861. doi:10.21873/anticanres.12147
   PubMed Web of Science ®Google Scholar
• Rudiger Siewert J, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg. 2000;232(3):353–361. doi:10.1097/00000658-200009000-00007
   PubMed Web of Science ®Google Scholar
• Lagarde SM, Ten Kate FJ, Richel DJ, et al. Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 2007;14(2):977–991. doi:10.1245/s10434-006-9262-y
   PubMed Web of Science ®Google Scholar
• Abdi E, Latifi-Navid S, Zahri S, et al. Risk factors predisposing to cardia gastric adenocarcinoma: insights and new perspectives. Cancer Med. 2019;8(13):6114–6126. doi:10.1002/cam4.2497
   PubMed Web of Science ®Google Scholar
• Matsuda T, Kurokawa Y, Yoshikawa T, et al. Clinicopathological characteristics and prognostic factors of patients with Siewert Type II esophagogastric junction carcinoma: a Retrospective Multicenter Study. World J Surg. 2016;40(7):1672–1679. doi:10.1007/s00268-016-3451-z
   PubMed Web of Science ®Google Scholar
• Ito H, Inoue H, Odaka N, et al. Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study. J Exp Clin Cancer Res. 2013;32:2. doi:10.1186/1756-9966-32-2
   PubMed Web of Science ®Google Scholar
• Imamura Y, Toihata T, Haraguchi I, et al. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses. Int j Cancer. 2021;148(5):1260–1275. doi:10.1002/ijc.33322
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang S, Zhu C, et al. The association between immune characteristic and clinical pathology in Chinese patients with adenocarcinoma of esophagogastric junction. Cancer Manag Res. 2020;12:3259–3269. doi:10.2147/CMAR.S235722
   PubMed Web of Science ®Google Scholar
• Imamura Y, Watanabe M, Oki E, et al. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: literature review and retrospective multicenter cohort study. Ann Gastroenterol Surg. 2021;5(1):46–59. doi:10.1002/ags3.12406
   PubMed Web of Science ®Google Scholar
• Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85(11):1457–1459. doi:10.1046/j.1365-2168.1998.00940.x
   PubMed Web of Science ®Google Scholar
• Swisher SG, Pisters PW, Komaki R, et al. Gastroesophageal junction adenocarcinoma. Curr Treat Options Oncol. 2000;1(5):387–398. doi:10.1007/s11864-000-0066-1
   PubMedGoogle Scholar
• Jung MK, Schmidt T, Chon SH, et al. Current surgical treatment standards for esophageal and esophagogastric junction cancer. Ann N Y Acad Sci. 2020;1482(1):77–84. doi:10.1111/nyas.14454
   PubMed Web of Science ®Google Scholar
• Nunobe S, Ida S. Current status of proximal gastrectomy for gastric and esophagogastric junctional cancer: a review. Ann Gastroenterol Surg. 2020;4(5):498–504. doi:10.1002/ags3.12365
   PubMed Web of Science ®Google Scholar
• Chen K, Deng X, Yang Z, et al. Survival nomogram for patients with metastatic Siewert type II adenocarcinoma of the esophagogastric junction: a population-based study. Expert Rev Gastroenterol Hepatol. 2020;14(8):757–764. doi:10.1080/17474124.2020.1784726
   PubMed Web of Science ®Google Scholar
• Dong H, Guo H, Xie L, et al. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma. PLoS One. 2013;8(5):e62986. doi:10.1371/journal.pone.0062986
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang W, Cheng Y, et al. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China. World J Surg Oncol. 2013;11:155. doi:10.1186/1477-7819-11-155
   PubMed Web of Science ®Google Scholar
• Al-Refaie WB, Tseng JF, Gay G, et al. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the national cancer data base. Cancer. 2008;113(3):461–469.
   PubMed Web of Science ®Google Scholar
• Zhong X, Xuan F, Qian Y, et al. A genomic-clinicopathologic Nomogram for the preoperative prediction of lymph node metastasis in gastric cancer. BMC Cancer. 2021;21(1):455.
   PubMed Web of Science ®Google Scholar
• Rubenstein JH, Raghunathan T, Doan C, et al. Validation of tools for predicting incident adenocarcinoma of the esophagus or esophagogastric junction. Am J Gastroenterol. 2021;116(5):949–957. doi:10.14309/ajg.0000000000001255
   PubMed Web of Science ®Google Scholar
• Graham AJ, Finley RJ, Clifton JC, et al. Surgical management of adenocarcinoma of the cardia. Am J Surg. 1998;175(5):418–421. doi:10.1016/S0002-9610(98)00040-3
   PubMed Web of Science ®Google Scholar
• Parshad R, Singh RK, Kumar A, et al. Adenocarcinoma of distal esophagus and gastroesophageal junction: long-term results of surgical treatment in a North Indian Center. World J Surg. 1999;23(3):277–283. doi:10.1007/PL00013179
   PubMed Web of Science ®Google Scholar
• Ellis FH Jr, Heatley GJ, Krasna MJ, et al. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg. 1997;113(5):836–846; discussion 846–838. doi:10.1016/S0022-5223(97)70256-3
   PubMed Web of Science ®Google Scholar
• Lin Y, Luo Y, Sun Y, et al. Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction. Nat Commun. 2020;11(1):6091. doi:10.1038/s41467-020-19949-6
   PubMed Web of Science ®Google Scholar
• DeCesaris CM, Berger M, Choi JI, et al. Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction. J Gastrointest Oncol. 2020;11(4):663–673. doi:10.21037/jgo-20-205
   PubMed Web of Science ®Google Scholar
• Narayan RR, Poultsides GA. Advances in the surgical management of gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol. 2021;6:16. doi:10.21037/tgh.2020.02.06
   PubMed Web of Science ®Google Scholar
• Schirren R, Novotny A, Slotta-Huspenina J, et al. Novel histologic categorization based on Lauren histotypes conveys prognostic information for gastroesophageal junction cancers-analysis from a large single center cohort in Germany. Cancers. 2021;13(6):1303.
   PubMed Web of Science ®Google Scholar